Susquehanna International Group
ORGO icon

Susquehanna International Group’s Organogenesis Holdings ORGO Stock Holding History

Susquehanna International Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.1K Sell
28,307
-39,002
-58% -$135K ﹤0.01% 12533
2025
Q4 		$349K Buy
67,309
+51,423
+324% +$249K ﹤0.01% 9592
2025
Q3 		$67K Sell
15,886
-109,124
-87% -$507K ﹤0.01% 11756
2025
Q2 		$458K Buy
125,010
+6,652
+6% +$24.8K ﹤0.01% 9381
2025
Q1 		$511K Buy
118,358
+69,639
+143% +$281K ﹤0.01% 8859
2024
Q4 		$156K Buy
48,719
+32,339
+197% +$109K ﹤0.01% 10982
2024
Q3 		$46.8K Buy
+16,380
New +$45.9K ﹤0.01% 11405
2024
Q2 		– Sell
-11,072
Closed -$29.7K – 12901
2024
Q1 		$31.4K Sell
11,072
-30,295
-73% -$103K ﹤0.01% 11703
2023
Q4 		$169K Sell
41,367
-343,643
-89% -$962K ﹤0.01% 10853
2023
Q3 		$1.22M Sell
385,010
-297,785
-44% -$946K ﹤0.01% 6180
2023
Q2 		$2.27M Sell
682,795
-75,051
-10% -$222K ﹤0.01% 4899
2023
Q1 		$1.61M Buy
+757,846
New +$1.87M ﹤0.01% 5623
2022
Q4 		– Sell
-26,554
Closed -$77.5K – 13326
2022
Q3 		$86K Sell
26,554
-34,531
-57% -$156K ﹤0.01% 11816
2022
Q2 		$298K Sell
61,085
-19,052
-24% -$117K ﹤0.01% 9579
2022
Q1 		$611K Sell
80,137
-60,466
-43% -$468K ﹤0.01% 8439
2021
Q4 		$1.3M Buy
140,603
+63,690
+83% +$676K ﹤0.01% 6569
2021
Q3 		$1.09M Sell
76,913
-81,075
-51% -$1.26M ﹤0.01% 7317
2021
Q2 		$2.63M Buy
157,988
+131,906
+506% +$2.46M ﹤0.01% 5321
2021
Q1 		$475K Buy
+26,082
New +$353K ﹤0.01% 9604
2019
Q2 		– Sell
-11,690
Closed -$88K – 10659
2019
Q1 		$88K Buy
+11,690
New +$233K ﹤0.01% 8298

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group's ORGO Position: Q1 2026 in Review

Susquehanna International Group reduced its Organogenesis Holdings (ORGO) stake by 58% in Q1 2026, selling an estimated $135K and leaving 28,307 shares worth $67.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12533.

Susquehanna International Group first reported a position in ORGO in Q1 2019 and has held it in 20 quarters since. The position peaked at $2.63M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Susquehanna International Group held 28,307 shares of Organogenesis Holdings worth $67.1K as of Q1 2026.
  • Susquehanna International Group sold 39,002 Organogenesis Holdings shares in Q1 2026, an estimated $135K.
  • Organogenesis Holdings made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12533 holding.
  • Susquehanna International Group first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 20 quarters since.
  • Susquehanna International Group's Organogenesis Holdings position peaked at $2.63M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.